FAM72C

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, FAM72C Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated FAM72C data layer compared with 25 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher FAM72C Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FAM72C expression acts as an unfavorable survival marker.

THYM are the cancer types where FAM72C Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
THYMOSMedianAll0.1860.931<.00115view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

FAM72C–THYM (OS)

Kaplan–Meier survival curve for FAM72C mutant vs wild-type samples in THYM.

Open the THYM breakdown →

Exploration